WHAT WE DO
We have already started funding cutting edge medical research into finding a cure for Bone Marrow Failure. To achieve this vision, we are working with a highly reputable Grants committee to develop National research strategy. We work Nationally to fund the research projects and people who we believe will find the breakthroughs this area of medicine so urgently needs.
What HAVE WE COMMITTED TO FUNDING?
- 2015 – 2018: The Australian Aplastic Anaemia Registry as a Means for Advancing Effective Treatment of Aplastic Anaemia (Transfusion Outcomes Research Collaborative (TORC). TORC is a consortium of members of Monash University Department of Epidemiology and Preventive Medicine at The Alfred Hospital, along with members of the Red Cross Blood Service)
- 2016-2019 (Fellowship): Prevention and treatment of bone marrow failure in Fanconi anaemia and other inherited disorders – part 1 (Dr Wayne Crismani, St Vincent’s Research Institute)
- 2016-2018 (Grant): Identification of miRNA biomarkers which play a functional role in disease pathogenesis and are predictive of inferior outcomes in AA/MDS (Dr Lynette Chee, Royal Melbourne Hospital)
- 2017-2020 (Fellowship): Genome editing of haematopoietic stem and progenitor cells to uncover novel therapeutics for aplastic anaemia and other bone marrow failure syndromes (Dr Yih-Chih Chan and Prof Mark Dawson, Sir Peter MacCallum Cancer Centre)
- 2017-2019 (Grant): Predicting malignant transformation of bone marrow failure syndromes using longitudinal targeted sequencing of peripheral blood and cell-free DNA (cfDNA) (Dr Piers Blombery, Victorian Comprehensive Cancer Centre)
- 2017-2019 (Grant): Prevention and treatment of bone marrow failure in Fanconi anaemia and other inherited disorders – part 2 (Dr Wayne Crismani, St Vincents Research Institute)
- 2018-2020 (Grant): Influences of clonal haematopoiesis in allogeneic bone marrow transplantation (Prof Mark Dawson and Dr Paul Yeh, Peter MacCallum Cancer Centre)
- 2018-2020: The Alex Gadomski Tasmanian Fellowship for Haematolgy in partnership with Menzies Institute
- 2019-2020 (Higher Degree Fellowship): The clinical, biomarker and genomic factors determining the outcome of Aplastic Anaemia in Australia (Dr Lucy Fox, University of Melbourne)
Professor David Ritchie
Professor David Ritchie is a Haematologist and Bone Marrow transplant specialist at the Royal Melbourne Hospital. He undertook his medical training and PhD in Immunology at the University of Otago before moving to Melbourne 10 years ago. He is head of the Bone Marrow Transplant Service of Royal Melbourne Hospital. He runs two research laboratories and is involved in all aspects of research into blood and bone marrow conditions. He is the immediate past president of the Haematology Society of Australia and New Zealand and is heavily involved in training young haematologists and medical researchers.
Professor David Haylock
Professor David Haylock brings considerable expertise in the isolation, characterization and ex vivo manipulation of human haemopoietic stem and progenitor cells to this initiative. Specifically, Professor Haylock has developed serum-free cytokine dependent culture systems for ex vivo expansion of haemopoietic stem cells (HSC) that enable analysis of the effect of purified recombinant cytokines on the proliferation and differentiation of HSC. Furthermore, he has significant skills in flow cytometric methods for multiparameter immunophenotypic analysis and fluorescent activated sorting of rare cell subsets. Recently, in collaboration with Professors Elefanty and Stanley (Monash University), this has involved detailed immunophenotypic characterisation of putative haemopoietic stem cells derived from differentiated hESC cultures. In addition, through his direction of the CRC-Polymers biomaterials project Prof Haylock has developed knowledge and expertise on biomaterials and bioreactor based systems for expansion of haemopoietic stem and progenitor cells. This includes the development of modified polymer surfaces that facilitate immobilisation of biological ligands for cell expansion. These skills and expertise will be utilised in development of novel systems for propagating megakaryocytes and producing platelets from hESC derived precursors.
Professor Suzanne Crowe AM
Professor Suzanne Crowe AM is a physician-scientist holding positions as the Associate Director of Burnet Institute, Consultant Infectious Diseases Physician at The Alfred hospital and Adjunct Professor of Infectious Diseases, Monash University. She also holds positions as a Non-Executive Director on the boards of St Vincent’s Health Australia and Avita Medical. Professor Crowe was appointed a Member of the Order of Australia (AM) in 2011, recognised for her service to HIV/AIDS medicine as an academician, clinician and researcher. She was appointed a Fellow of the Australian Academy of Health and Medical Sciences in 2015.
DR RACHEL CONYERS
Dr Rachel Conyers is a paediatric,
adolescent and young adult malignant haematologist/oncologist. Dr Conyers
completed her medical degree at Monash University in 2003. Completing
fellowships in Paediatric Oncology at The Royal Children’s Hospital (Melbourne),
Bone Marrow Transplantation (Great Ormond Street Hospital, London) and
Adolescent Young Adult Sarcoma (University College Hospital, London). Returning
to Australia in 2010, Rachel began an Adult and Adolescent fellowship in
Haematology at Peter MacCallum Cancer Centre whilst completing her PhD in
sarcoma pharmacogenomics and genetics. In 2016 Dr Conyers was awarded a
Clinician Scientist Fellowship at Murdoch Children’s Research Institute
(2016-2019). This research fellowship will allow her to continue her research
into the genetic predisposition to chemotherapy side effects (mainly
anthracycline cardiomyopathy). In 2016 Dr Conyers also co-founded Treat Unique,
an Adolescent and Young Adult Oncology and Haematology service in the private
sector. Currently Rachel works as a Bone
Marrow Transplant Physician at The Royal Children’s Hospital and in Adult and
Young Adult Haematology at the Victorian Comprehensive Cancer Centre,
Professor Hatem Salem AM
Hatem Salem is an Emeritus Professor at Monash University. Prior to this, Professor Salem was the Head of the Academic Department of Clinical Haematology at Monash University and the Head of Clinical Haematology at the Alfred Hospital. He served as President of Asia Pacific Society of Thrombosis and Haemostasis and past president and Executive Director of the Australasian Society of Thrombosis and Hemostasis. He is a senior Counsellor of the International Society of Thrombosis and Haemostasis. His clinical and laboratory research interest is in the field of thrombosis and haemostasis. He has published in excess of 140 peer reviewed articles in International journals, received many awards and grants throughout his career, and has supervised the training of many PhD graduates. In 2005, his vision and ability to develop leading clinical and research programs was recognised by the Victorian Government’s Public Healthcare Award, where he was the recipient of the Health Minister’s Award for Outstanding Individual Achievement.
In 2010, Professor Hatem Salem was awarded the Member of the Order of Australia (AM) for service to medicine in the field of haematology as a clinician, educator and researcher and also through the establishment of the Australian Centre for Blood Diseases.
Hatem Salem is a Fellow of the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia, a licentiate and member of the Royal College of Physicians (UK) and a member of the Royal College of Surgeons (London). He received his doctorate degree from Monash University in 1984 and his basic medical degree from the University of Mosul, Iraq in 1977.